G1 Therapeutics to release Q2 2024 financial results and corporate update on August 8, 2024.

G1 Therapeutics, a commercial-stage oncology company, will release its Q2 2024 financial results and provide a corporate update on August 8, 2024, at 8:30 a.m. ET. The webcast and conference call details can be found at their website for registration. The live and archived webcast will be accessible on the company's site for 90 days post-event. Based in Research Triangle Park, NC, G1 Therapeutics focuses on innovative cancer therapies, including their commercial product, COSELA® (trilaciclib).